Treatment of chronic hepatitis delta with pegylated interferon-alpha2b

Chronic hepatitis D is difficult to treat. The present pilot study investigated the efficacy and tolerability of pegylated (PEG)-interferon (IFN)-alpha2b in chronic hepatitis D. Twelve patients with chronic hepatitis D were prospectively treated with 1.5 microg/kg PEG-IFN-alpha2b for 48 weeks and fo...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Liver international 2006-09, Vol.26 (7), p.805
Hauptverfasser:	Erhardt, Andreas, Gerlich, Wolfram, Starke, Christine, Wend, Ulrike, Donner, Andreas, Sagir, Abdurrahman, Heintges, Tobias, Häussinger, Dieter
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Antiviral Agents - administration & dosage Antiviral Agents - adverse effects Female Genome, Viral Hepatitis B virus - genetics Hepatitis B virus - isolation & purification Hepatitis D, Chronic - drug therapy Hepatitis D, Chronic - pathology Hepatitis D, Chronic - virology Hepatitis Delta Virus - genetics Hepatitis Delta Virus - isolation & purification Humans Interferon-alpha - administration & dosage Interferon-alpha - adverse effects Liver - pathology Male Middle Aged Pilot Projects Polyethylene Glycols Recombinant Proteins
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!